WOSULIN N

This brand name is authorized in Nigeria.

Active ingredients

The drug WOSULIN N contains one active pharmaceutical ingredient (API):

1	Insulin (human) UNII 1Y17CTI5SR - INSULIN HUMAN
	The blood glucose lowering effect of insulin is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver.
	Read more about Insulin (human)

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A6-0239	Suspension for injection	Wosulin N Suspension for Injection 100 IU/mL Vial INJ_SUSP 1000 units/10 mL 10 mL x 1's (in multi-dose vial)	Suspension for injection	21/12/2023
A6-0333	Suspension for injection	Wosulin N Suspension for Injection 100 IU/mL Cartridge INJ_SUSP 300 units/3 mL 3 mL x 1's (in multi-dose cartridge)	Suspension for injection	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10AC01	Insulin (human)	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AC Insulins and analogues for injection, intermediate-acting
Discover more medicines within A10AC01
A10AD01	Insulin (human)	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AD Insulins and analogues for injection, intermediate-acting combined with fast-acting
Discover more medicines within A10AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A6-0239, A6-0333